Lung Cancers Completed Phase 2 Trials for Celecoxib (DB00482)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00055978Celecoxib in Preventing Lung Cancer in Former Heavy SmokersPrevention
NCT00070486Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00068653Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung CancerTreatment
NCT00058006Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung CancerTreatment
NCT00062179Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung CancerTreatment
NCT00030420Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00030407Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung CancerTreatment
NCT00020878Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco SmokersPrevention